Company Number: 15162396

Analysis Date: 2025-07-20 18:57 UTC

1. Risk Rating: HIGH
   Given the company’s dormant status since incorporation in September 2023, minimal financial activity, and negligible net assets (£0), the risk of solvency and liquidity issues is high should the company commence trading without capital infusion. The absence of operating history and financial substance limits confidence in operational sustainability.

2. Key Concerns:

• Dormant Status with No Operating History: The company has filed dormant accounts for the first financial year, indicating no trading activity or revenue generation yet. This raises questions about its business viability and future cash flows.
• Minimal Financial Resources: Net assets and net current assets are effectively zero, with only £1 called-up share capital not paid, suggesting no meaningful capital buffer to meet obligations.
• Single Director and PSC Concentration: One director (Ms Souad Sassi) holds 75-100% control and voting rights, concentrating governance and control risk, which may affect operational oversight and decision-making transparency.

3. Positive Indicators:

• Compliance with Filing Requirements: The company has submitted accounts and confirmation statements on time, indicating regulatory compliance and good governance fundamentals at this early stage.
• Clear Accounting Policies: The accounts document reflects adherence to FRS 105 and Companies Act 2006 requirements, suggesting proper financial reporting framework is in place.
• Registered Office in London: A credible business address may facilitate future operational activities and stakeholder engagement.

4. Due Diligence Notes:

• Investigate the company’s business plan and funding sources to understand how it intends to generate revenue and finance operations going forward.
• Confirm whether the single director/PSC has other business interests or operational experience in residential care activities (SIC 87900).
• Monitor future filings for trading activity, asset acquisition, and capital injections to assess whether the company transitions from dormant status to active operations sustainably.
• Review any related party transactions or loans that may not be reflected in the dormant accounts but could impact financial stability.